Medifast, Inc.

Equities

MED

US58470H1014

Food Processing

Real-time Estimate Cboe BZX 03:11:30 2024-03-28 pm EDT 5-day change 1st Jan Change
38.52 USD +2.64% Intraday chart for Medifast, Inc. +8.25% -42.61%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Medifast, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : Medifast, Inc., Q4 2023 Earnings Call, Feb 20, 2024
Earnings Flash (MED) MEDIFAST Posts Q4 EPS $1.09, vs. Street Est of $0.96 MT
Earnings Flash (MED) MEDIFAST Reports Q4 Revenue $191M, vs. Street Est of $184.2M MT
Medifast Provides Earnings Guidance for the First Quarter of 2024 CI
Medifast, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Health Care Climbs After Fed Policy Move -- Health Care Roundup DJ
Medifast, LifeMD Collaborate to Offer Weight Management Solution; Medifast Scraps Quarterly Dividend MT
Transcript : LifeMD, Inc., Medifast, Inc. - Special Call
Medifast's Board of Directors Elect to Discontinue the Company's Quarterly Cash Dividend CI
Medifast Initiates Business Transformation by Entering the Medically Supported Weight Loss Market through Collaboration with LifeMD, Inc CI
Tranche Update on Medifast, Inc.'s Equity Buyback Plan announced on December 9, 2013. CI
Medifast, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Medifast, Inc., Q3 2023 Earnings Call, Nov 06, 2023
Earnings Flash (MED) MEDIFAST Posts Q3 Revenue $235.9M, vs. Street Est of $232.1M MT
Medifast, Inc. Provides Earnings Guidance for the Full Year 2023 CI
Stephens Initiates Medifast With Equalweight Rating, Price Target is $82 MT
Medifast Unveils Supplements for Muscle Health MT
Medifast, Inc. Announces Optavia Active Now Available CI
Medifast Keeps Quarterly Dividend at $1.65 a Share, Payable Nov. 7 to Shareholders of Record Sept. 19 MT
Medifast, Inc. Declares Quarterly Cash Dividend, Payable on November 7, 2023 CI
Insider Sell: Medifast MT
Medifast Q2 Net Income, Revenue Fall; Q3 Outlook Set -- Shares Jump After-Hours MT
Tranche Update on Medifast, Inc.'s Equity Buyback Plan announced on December 9, 2013. CI
Transcript : Medifast, Inc., Q2 2023 Earnings Call, Aug 07, 2023
Chart Medifast, Inc.
More charts
Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
37.53 USD
Average target price
37.5 USD
Spread / Average Target
-0.08%
Consensus
  1. Stock
  2. Equities
  3. Stock Medifast, Inc. - Nyse
  4. News Medifast, Inc.
  5. Medifast : CEO Chard Adds Executive Chairman Role